Seqalis offers the following analytical services:
- T Cell Repertoire Sequencing (qTCR-seq) for quantitative monitoring of T cell receptors in immuno-oncology and vaccinology,
- Cytogenomics for quality control in cell and gene therapy,
- And NGS sequencing (WGS, Total RNA-seq, etc.) of micro-organisms, among others.
Backed by its 20 years’ experience and the support of the IPG (Institut de Pathologie et de Génétique), of which it is a member, Seqalis offers pharmaceutical companies, biotechs and universities cutting-edge analysis services and sound medical-scientific advice in the fields of Molecular Biology, Cytogenomics and Anatomo-Pathology.
Thanks to its close links with the IPG, Seqalis also benefits from privileged access to the Walloon hospital network.
Seqalis has set up an operational structure focused on customer satisfaction and long-term support for R&D projects and clinical trials.
Seqalis – Fostering Progress in Life Sciences
Contact
Jean-Luc Henrioul, COO
jl.henrioul@seqalis.com
Tel : +32 (0)71 347 819
